Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.
@article{Galsky2011TreatmentOP, title={Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.}, author={M. Galsky and N. Hahn and J. Rosenberg and G. Sonpavde and T. Hutson and W. Oh and R. Dreicer and N. Vogelzang and C. Sternberg and D. Bajorin and J. Bellmunt}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2011}, volume={29 17}, pages={ 2432-8 } }
PURPOSE
Cisplatin-based combination chemotherapy is considered standard first-line treatment for patients with metastatic urothelial carcinoma. However, a large proportion of patients with metastatic urothelial carcinoma are considered "unfit" for cisplatin. The purpose of this review is to define unfit patients and to identify treatment options for this subgroup of patients.
PATIENTS AND METHODS
In this review, the criteria used to define unfit patients are explored and the results of… CONTINUE READING
Paper Mentions
Interventional Clinical Trial
Cabozantinib plus Durvalumab in patients with advanced and chemotherapy-treated bladder
carcinoma, of urothelial and non-urothelial histology: an open-label, single-centre, phase 2… Expand
Conditions | Bladder Carcinoma |
---|---|
Intervention | Drug |
Interventional Clinical Trial
Phase II Multicentre, randomized, open-label study to evaluate the safety and efficacy of
avelumab with gemcitabine/carboplatin versus gemcitabine/carboplatin alone in patients with… Expand
Conditions | Metastatic Urothelial Cancer |
---|---|
Intervention | Combination Product |
283 Citations
Administration of cisplatin-based chemotherapy for advanced urothelial carcinoma in the community.
- Medicine
- Clinical genitourinary cancer
- 2012
- 37
Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer
- Medicine
- Current Treatment Options in Oncology
- 2019
- 4
Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens.
- Medicine
- Clinical genitourinary cancer
- 2020
Cisplatin Ineligibility for Patients With Metastatic Urothelial Carcinoma: A Survey of Clinical Practice Perspectives Among US Oncologists
- Medicine
- 2019
- 1
- PDF
Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer.
- Medicine
- Urologic oncology
- 2014
- 22
Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?
- Medicine
- The Journal of urology
- 2012
- 37
Cisplatin-ineligible and chemotherapy-ineligible patients should be the focus of new drug development in patients with advanced bladder cancer.
- Medicine
- Clinical genitourinary cancer
- 2014
- 27
Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
- Medicine
- Nature Reviews Urology
- 2021
References
SHOWING 1-10 OF 72 REFERENCES
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2007
- 44
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2011
- 56
- PDF
A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy.
- Medicine
- The Lancet. Oncology
- 2011
- 163
Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity.
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2011
- 106
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma.
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 2012
- 89
Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience
- Medicine
- Anti-cancer drugs
- 2009
- 11
Single-Agent Gemcitabine in Previously Untreated Elderly Patients with Advanced Bladder Carcinoma: Response to Treatment and Correlation with the Comprehensive Geriatric
- Medicine
- Oncology
- 2004
- 47
Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.
- Medicine
- European urology
- 2003
- 26
Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: a phase II clinical trial.
- Medicine
- Annals of oncology : official journal of the European Society for Medical Oncology
- 1999
- 133